Registrational phase 2 trial of sotorasib in KRAS p.G12C mutant NSCLC: First disclosure of the CodeBreaK 100 primary analysis Meeting Abstract
| Authors: | Li, B.; Skoulidis, F.; Falchook, G.; Sacher, A.; Velcheti, V.; Dy, G.; Price, T.; Borghaei, H.; Schuler, M.; Kato, T.; Takahashi, T.; Spira, A.; Ramalingam, S.; Besse, B.; Barlesi, F.; Tran, Q.; Henary, H.; Ngarmchamnanrith, G.; Govindan, R.; Wolf, J. |
| Abstract Title: | Registrational phase 2 trial of sotorasib in KRAS p.G12C mutant NSCLC: First disclosure of the CodeBreaK 100 primary analysis |
| Meeting Title: | 2020 World Conference on Lung Cancer |
| Keywords: | nsclc; kras p.g12c; sotorasib (amg 510) |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 16 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 28-31 |
| Meeting Location: | Singapore |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-03-01 |
| Start Page: | S61 |
| Language: | English |
| ACCESSION: | WOS:000631349600005 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2021.01.321 |
| Notes: | Meeting Abstract: PS01.07 -- Due to Covid-19 pandemic, the conference was held virtually -- Source: Wos |
